ArticleMalaria journal2015

Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes.

Jeanne Rini Poespoprodjo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.